ASHLEY THURMAN: Open Payments
NPI 1629207071 · MCMINNVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 77 payments from 20 companies in 2025. Trend: 2023 $1,621 · 2024 $1,463 · 2025 $1,602
Food & beverage: $1,602
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $220 |
| Novartis Pharmaceuticals Corporation | 11 | $203 |
| ABBVIE INC. | 9 | $160 |
| GENZYME CORPORATION | 4 | $124 |
| UCB, Inc. | 5 | $113 |
| Janssen Biotech, Inc. | 4 | $101 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| Amgen Inc. | 5 | $95 |
| LEO Pharma Inc. | 4 | $78 |
| Lilly USA, LLC | 4 | $63 |
Products named: DUPIXENT, ILUMYA, COSENTYX, Bimzelx, TREMFYA, OTEZLA, RINVOQ, SKYRIZI.
Industry payments across TN — which companies pay providers there.
